{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:49:59Z","timestamp":1774543799195,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:p>We read with interest the article by Cheng et al., who evaluated patients with spongiotic psoriasiform dermatitis using histopathological and multiplex immunofluorescence analyses. We add some new perspectives and provide a few suggestions.<\/jats:p>","DOI":"10.1093\/ced\/llaf544","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:45:06Z","timestamp":1765716306000},"page":"648-648","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u2018Spongiotic psoriasiform dermatitis with dual features of eczema and psoriasis: Janus kinase inhibition as a potential therapeutic option\u2019: a new therapy"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-1391","authenticated-orcid":false,"given":"Gao","family":"Chao","sequence":"first","affiliation":[{"name":"Department of Dermatology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine , Jinhua, Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zhoushan Hospital, Wenzhou Medical University , Zhoushan, Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026032611530282400_llaf544-B1","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/ced\/llaf336","article-title":"Spongiotic psoriasiform dermatitis with dual features of eczema and psoriasis: Janus kinase inhibition as a potential therapeutic option","volume":"50","author":"Cheng","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026032611530282400_llaf544-B2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jaad.2025.05.002","article-title":"Differentiating psoriasis from eczema with interleukin-36 gamma immunohistochemistry on skin biopsy specimens: a retrospective, single-center validation and cohort study","volume":"93","author":"DaCosta","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"2026032611530282400_llaf544-B3","doi-asserted-by":"crossref","first-page":"e2531204","DOI":"10.1001\/jamanetworkopen.2025.31204","article-title":"Comparative safety of JAK inhibitors vs TNF antagonists in immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"8","author":"Solitano","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"Suppl 2","key":"2026032611530282400_llaf544-B4","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/rheumatology\/keab024","article-title":"JAK1: number one in the family; number one in inflammation?","volume":"60","author":"Spinelli","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"2026032611530282400_llaf544-B5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ard.2025.05.542","article-title":"POS0154 Comparative safety outcomes of tofacitinib versus upadacitinib in patients with rheumatoid arthritis: a retrospective cohort study","volume":"84","author":"Khasho","year":"2025","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf544\/65885351\/llaf544.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/648\/65885351\/llaf544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/648\/65885351\/llaf544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:53:07Z","timestamp":1774540387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/4\/648\/8380273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":5,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,15]]},"published-print":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf544","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,15]]}}}